Curio Prepares To Launch Postpartum Depression Digital Therapeutic With $10M In New Funding

 
• By Natasha Barrow

MamaLift Plus, 510(k)-cleared by the FDA in April as the first prescription digital therapeutic for treating postpartum depression, will soon be available for download on the App Store or Google Play. Announced 28 August, Curio has raised $10m in Series A funding to bolster commercial activities.

Postpartum depression is estimated to affect one in seven new mothers and represents billions in financial costs each year. • Source: Shutterstock

More from Financing

More from Business